Monteris Medical raises $30m Series B round for NeuroBlate robotic brain tumor laser

Monteris Medical says it's drummed up a $30 million Series B round for its NeuroBlate laser robotic surgery platform.

Monteris Medical said a pair of new backers joined a $30 million Series B round it plans to use to expand the commercial footprint of its NeuroBlate robotic brain tumor laser.

BDC Capital Healthcare Fund, Birchview Capital, Monteris Medical, The Vertical Group

News Well, Funding Roundup, Laser/Light-based Devices, Neurological, Robot-Assisted Surgery

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1tMNOh9